Lipitor Sales

ALL
News
Opinion
Photos
Videos

Jump to

Ranbaxy puts past to rest, bright future ahead: Macquarie

Pharma analyst at Macquarie Research, Abhishek Singhal, spoke to CNBC-TV18 about the key takeaways from the management meet post Ranbaxy’s settlement with the US FDA.
Teva will get part of profit from Lipitor sale by Ranbaxy

Industry sources tell PharmAsia News that Ranbaxy forged the Teva Lipitor deal as a back-up plan to try and ensure an on-time launch.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Lipitor Sales

Ranbaxy puts past to rest, bright future ahead: Macquarie

Teva will get part of profit from Lipitor sale by Ranbaxy